The first nasally administered naloxone-based therapy to treat emergency cases of opioid overdose from heroin or prescription painkillers received a Fast Track Designation from the FDA, product developer AntiOp said in a July 15 statement.
FDA's May 28 approval of Natesto, the first nasally delivered testosterone gel for hypogonadism, came just in time for Canada's Trimel Pharmaceuticals, which had just $18 million left on hand at the beginning of the year.
Reckitt Benckiser Pharmaceuticals announced May 19 that it is codeveloping what would be the first nasally administered naloxone-based therapy to treat emergency cases of opioid overdose from heroin or prescription painkillers.
A nasal spray could offer a new route by which to administer a peptide used to treat depression, as published in a new study by researchers at the Toronto, Canada-based Centre for Addiction and Mental Health. It's the first time this type of delivery has been used to treat the condition.
Acorda Therapeutics posted positive results of its first clinical feasibility study of its diazepam nasal spray to treat patients with epilepsy.
Researchers at Northeastern University have developed a treatment for Parkinson's disease meant to revive dying neurons in the brain via delivery through the nose.
An Indiana University School of Medicine team is using a $3 million, three-year grant from the U.S. Army to develop a nanoparticle nasal spray to curb suicides.
The Biomedical Advanced Research and Development Authority (BARDA) has awarded $4.4 million to the Southwest Research Institute (SwRI) in San Antonio to develop a nasal-delivery version of a cyanide
Insulin, delivered in a nasal spray, seems to improve cognitive function in Alzheimer's patients, according to research appearing in the Journal of Neurology. Nasal delivery is appropriate because
Through the nose might be a better, non-invasive route to pain relief using a "pressurized olfactory device" (POD) to deliver opioid drugs, according to research outlined in the September issue of